quadgram

This is a table of type quadgram and their frequencies. Use it to search & browse the list to learn more about your study carrel.

quadgram	frequency
hematopoietic stem cell transplantation	897
of conflict of interest	480
disclosure of conflict of	479
allogeneic hematopoietic stem cell	449
allogeneic stem cell transplantation	359
at the time of	337
graft versus host disease	259
hematopoietic stem cell transplant	186
autologous stem cell transplantation	184
with a median follow	164
for the treatment of	160
of this study was	151
peripheral blood stem cell	150
this study was to	147
in the setting of	147
a total of patients	145
after allogeneic hematopoietic stem	143
at a median of	139
peripheral blood stem cells	139
the aim of this	139
median age was years	133
abstract case report text	132
haematopoietic stem cell transplantation	127
stem cell transplantation in	116
in the treatment of	116
aim of this study	116
a median of days	111
the cumulative incidence of	110
in the absence of	109
a median age of	106
after allogeneic stem cell	105
allogeneic hematopoietic cell transplantation	103
median follow up of	101
with a median age	98
after hematopoietic stem cell	98
the majority of patients	95
stem cell transplant recipients	92
acute and chronic gvhd	92
a median follow up	90
the median age was	89
stem cell transplantation for	86
the median time to	85
has been shown to	84
were included in the	83
at the age of	82
after a median follow	80
p disclosure of conflict	80
as well as the	79
blood stem cell transplantation	78
in a patient with	78
a median time of	76
in the presence of	75
the median age at	73
this is the first	73
is one of the	72
was found to have	71
at the end of	70
of the patients with	70
median age of years	70
with a history of	70
there was no significant	69
nothing to declare background	68
acute graft versus host	68
of morbidity and mortality	68
cumulative incidence of relapse	68
the median number of	68
is associated with a	67
there was no difference	67
the median age of	66
of hematopoietic stem cell	65
was associated with a	65
in hematopoietic stem cell	65
was found to be	64
blood and marrow transplantation	64
patients were treated with	64
patients with hematological malignancies	62
in the context of	62
studies are needed to	62
morbidity and mortality in	61
in lung transplant recipients	61
at a dose of	60
at years of age	59
safety and efficacy of	59
study was to evaluate	58
source of stem cells	58
has been associated with	58
an increased risk of	58
autologous hematopoietic stem cell	58
we performed a retrospective	57
it is important to	57
of allogeneic hematopoietic stem	57
no significant difference in	57
median time to neutrophil	56
stem cell source was	55
a retrospective chart review	54
after stem cell transplantation	53
was no significant difference	53
is the most common	53
to be associated with	53
number of cd cells	53
for the development of	52
neutrophil and platelet engraftment	52
nothing to declare p	52
cause of morbidity and	52
patients with multiple myeloma	52
are shown in table	52
patients with hematologic malignancies	52
allogeneic haematopoietic stem cell	51
in pediatric patients with	51
on the other hand	51
after bone marrow transplantation	50
of acute and chronic	50
allogeneic stem cell transplant	50
been shown to be	50
as a result of	50
at months of age	50
stem cell transplantation is	50
cd and cd t	50
there were no significant	49
included in the study	49
at a median follow	49
acute or chronic gvhd	48
peripheral blood mononuclear cells	48
allogeneic bone marrow transplantation	48
with sickle cell disease	48
haploidentical stem cell transplantation	48
the conditioning regimen was	47
in of the patients	47
the median duration of	47
was to evaluate the	47
was significantly higher in	46
was no difference in	46
with a median of	46
for the first time	46
one of the most	45
in the majority of	45
we conducted a retrospective	45
total of patients were	45
the purpose of this	45
should be considered in	45
case report text introduction	45
for blood and marrow	45
a retrospective analysis of	45
incidence of acute gvhd	44
in patients who received	44
of the immune system	44
was observed in patients	44
of the patients who	44
in a cohort of	44
conditioning regimen consisted of	44
chronic graft versus host	44
none of the patients	43
there were no differences	43
of this study is	43
in the united states	43
time from diagnosis to	43
an important role in	43
national institutes of health	43
associated with an increased	43
with acute myeloid leukemia	43
as part of the	42
gvhd prophylaxis consisted of	42
were included in this	42
the age of years	42
this study is to	42
is the only curative	41
the safety and efficacy	41
blood and marrow transplant	41
in patients with hematologic	41
with a median time	41
caused by mutations in	40
patients with acute leukemia	40
follow up of months	40
the outcome of patients	40
patients who did not	40
have been associated with	40
the aim of the	39
to the development of	38
in patients treated with	38
during the study period	38
option for patients with	38
in allogeneic stem cell	38
a major cause of	38
between the two groups	38
causes of death were	38
lower respiratory tract disease	38
a risk factor for	38
the case of a	38
have been reported in	38
the number of cd	38
little is known about	38
of the patients had	38
age at transplant was	37
no significant differences in	37
retrospective chart review of	37
after a median of	37
in the development of	37
the incidence of acute	37
of the study was	37
of the patients were	36
dose of mg kg	36
a cohort of patients	36
autologous peripheral blood stem	36
the stem cell source	36
were no significant differences	36
have been shown to	36
on the use of	36
in the first days	36
the end of the	36
was the most common	36
patients with high risk	35
transplantation in patients with	35
in patients with acute	35
of the conditioning regimen	35
in the era of	35
the median time from	35
a matched unrelated donor	35
median age of the	35
were found to be	34
acute gvhd grade ii	34
the only curative treatment	34
year cumulative incidence of	34
respiratory viral infections in	34
were more likely to	34
following hematopoietic stem cell	34
the main cause of	34
the objective of this	34
aim of the study	34
at a median time	34
and autologous stem cell	34
median age at transplant	34
objective of this study	34
and cd t cells	34
case report text background	33
on the basis of	33
x cd cells kg	33
in this study we	33
acute respiratory distress syndrome	33
significantly higher in the	33
of allogeneic stem cell	33
play a role in	32
no statistically significant difference	32
efficacy and safety of	32
the time of the	32
median age at diagnosis	32
on the outcome of	32
median time of days	32
at the same time	32
in the general population	32
was not associated with	32
of the patients was	32
the presence of a	32
patients with sickle cell	32
of hematopoietic stem cells	31
were found to have	31
the time of diagnosis	31
treatment for patients with	31
patients with acute myeloid	31
with the use of	31
report a case of	31
in patients with aml	31
stem cell transplantation with	31
between january and december	31
outcome of patients with	31
of respiratory syncytial virus	31
those who did not	31
he was treated with	31
and the use of	31
found to have a	31
reduced intensity conditioning regimen	31
of a patient with	31
cohort of patients with	31
with an increased risk	31
a dose of mg	31
after allogeneic hematopoietic cell	31
was defined as the	30
patients with a median	30
of patients who received	30
there was a trend	30
he was diagnosed with	30
working party of the	30
a higher risk of	30
with the development of	30
in the group of	30
a reduced intensity conditioning	30
of patients who underwent	30
we present a case	30
during the first year	29
we were able to	29
bone marrow transplant recipients	29
respiratory syncytial virus infection	29
and is associated with	29
for the prevention of	29
hematopoietic cell transplant recipients	29
play an important role	29
incidence of chronic gvhd	29
significant morbidity and mortality	29
at high risk for	29
were no differences in	29
in patients with hematological	29
reduce the risk of	29
in patients with high	29
a significant increase in	29
of the patients received	29
the quality of life	29
conditioning regimen was myeloablative	29
acute and chronic graft	29
the first days after	29
was significantly associated with	29
and the presence of	29
for the management of	29
we report a case	29
patients were included in	29
purpose of this study	29
median age at hsct	29
and hematopoietic stem cell	28
was to assess the	28
the median time of	28
patients who underwent allogeneic	28
no conflict of interest	28
she was started on	28
reported in the literature	28
at high risk of	28
cause of death in	28
patients were diagnosed with	28
to be effective in	28
in addition to the	28
our data suggest that	28
in the last years	28
in the pathogenesis of	28
in the first year	28
further studies are needed	28
a high rate of	28
and total body irradiation	28
evaluate the impact of	28
respiratory virus infections in	28
treatment of patients with	28
to neutrophil and platelet	28
allergy and infectious diseases	27
institute of allergy and	27
has been reported to	27
most of the patients	27
national institute of allergy	27
age of the patients	27
the development of a	27
a year old male	27
source was peripheral blood	27
more likely to have	27
in the peripheral blood	27
patient was started on	27
at the start of	27
and the development of	27
in the number of	27
was not statistically significant	27
was significantly lower in	27
t and b cell	27
of allergy and infectious	27
associated with a higher	27
diagnosis and management of	27
hematopoietic stem cell transplants	27
with acute lymphoblastic leukemia	27
in the bone marrow	26
patient was diagnosed with	26
in the multivariate analysis	26
median time from diagnosis	26
we retrospectively analyzed the	26
with the exception of	26
or in combination with	26
in adult patients with	26
in the present study	26
of patients with a	26
stem cell transplantation from	26
patients are alive and	26
in patients with a	26
patient was treated with	26
t cells in the	26
with a diagnosis of	26
diagnosis and treatment of	26
b and nk cells	26
incidence and severity of	26
large b cell lymphoma	26
in the management of	26
the study was to	26
in allogeneic hematopoietic stem	26
and quality of life	25
median age of patients	25
as compared to the	25
in patients undergoing allogeneic	25
age at hsct was	25
compared to patients with	25
the time of hsct	25
by mutations in the	25
morbidity and mortality after	25
during the first days	25
therapy in patients with	25
included in this study	25
a matched related donor	25
in the control group	25
the time of transplant	25
the first year after	25
group for blood and	25
increase the risk of	25
bone marrow transplantation in	25
of cd t cells	25
diffuse large b cell	25
a higher incidence of	25
in this patient population	25
to evaluate the impact	25
associated with increased risk	25
is known about the	25
time to neutrophil engraftment	25
study was to analyze	25
had at least one	24
followed by autologous stem	24
median age at transplantation	24
were the most common	24
in vitro and in	24
he was found to	24
of patients treated with	24
there was no statistically	24
and the number of	24
patients with and without	24
was peripheral blood in	24
of cd and cd	24
significant difference in the	24
t and b cells	24
on the day of	24
for hematopoietic stem cell	24
were in complete remission	24
from an unrelated donor	24
the first year of	24
median time to platelet	24
in the case of	24
patients who underwent hsct	24
our results suggest that	24
haploidentical hematopoietic stem cell	24
lower respiratory tract infections	24
area under the curve	24
in the course of	24
source was bone marrow	24
associated with a lower	24
after autologous stem cell	24
age of patients was	24
recipients of hematopoietic stem	24
has the potential to	24
of minimal residual disease	24
in this retrospective study	23
in first complete remission	23
engraftment was achieved in	23
was approved by the	23
in the immunocompromised host	23
cell transplantation in patients	23
study is to evaluate	23
in patients who underwent	23
for acute myeloid leukemia	23
a retrospective study of	23
of cd cells in	23
a significant decrease in	23
solid organ transplant recipients	23
cumulative incidence of grade	23
our aim was to	23
patients who received a	23
of acute gvhd grade	23
for a median of	23
with no evidence of	23
received peripheral blood stem	23
allogeneic peripheral blood stem	23
umbilical cord blood transplantation	23
of our study was	23
has been reported in	23
switched memory b cells	23
the majority of the	23
patients died due to	23
specific cd t cells	23
in patients with multiple	23
by autologous stem cell	23
european group for blood	23
in patients who had	23
with increased risk of	23
similar in both groups	22
for the diagnosis of	22
these data suggest that	22
quality of life of	22
a median of months	22
are summarized in table	22
cd t cells were	22
patients with haematological malignancies	22
retrospective chart review was	22
was no statistically significant	22
following allogeneic hematopoietic stem	22
from january to december	22
was to analyze the	22
study was to assess	22
the course of the	22
a case of a	22
these results suggest that	22
the proportion of patients	22
time to neutrophil and	22
the efficacy and safety	22
are the most common	22
incidence of grade ii	22
dose chemotherapy followed by	22
patients with primary immunodeficiency	22
we report our experience	22
compared to healthy controls	22
associated with a high	22
total of patients with	22
autologous stem cell transplant	22
with the addition of	22
bronchiolitis obliterans organizing pneumonia	22
course was complicated by	22
a retrospective review of	22
allogenic hematopoietic stem cell	22
present a case of	22
a median number of	22
there was a significant	22
age at diagnosis was	22
up to of patients	22
infections in patients with	22
present the case of	22
the risk of relapse	22
haematopoietic stem cell transplant	22
no conflicts of interest	22
small number of patients	22
this is a retrospective	22
the aim of our	22
in patients with severe	22
patients who had undergone	22
a high incidence of	22
age at transplantation was	22
the time of transplantation	22
had a history of	22
proportion of patients with	22
is a primary immunodeficiency	22
were not significantly different	21
the number of patients	21
have been reported to	21
the development of allo	21
she was treated with	21
a large cohort of	21
hsct in patients with	21
review of the literature	21
a matched sibling donor	21
in children with scd	21
group and in the	21
is to evaluate the	21
was used in patients	21
infectious diseases working party	21
in hematopoietic cell transplant	21
were associated with a	21
iv acute gvhd was	21
be considered in patients	21
median follow up was	21
of the patients in	21
following allogeneic stem cell	21
enrolled in the study	21
therapy for patients with	21
of graft versus host	21
we present the case	21
and are associated with	21
patients with r r	21
all patients received a	21
this group of patients	21
can be used to	21
idiopathic pneumonia syndrome after	21
as stem cell source	21
severe combined immune deficiency	21
test was used to	21
of acute or chronic	21
who were treated with	21
the overall response rate	21
in the two groups	21
the group of patients	21
of t and b	21
the first case of	21
lower respiratory tract infection	21
for patients with high	21
our study was to	21
he was started on	21
to evaluate the efficacy	21
for the majority of	21
be considered as a	21
the european group for	21
were enrolled in the	21
a single center experience	21
at different time points	21
with autologous stem cell	21
in children and adolescents	21
the results of the	21
the only curative option	20
as well as in	20
may be associated with	20
the patient was started	20
patients with relapsed refractory	20
were significantly associated with	20
the conditioning regimen consisted	20
at the last follow	20
mg m for days	20
autologous haematopoietic stem cell	20
described in the literature	20
neutrophil and platelet recovery	20
the median follow up	20
of chronic gvhd was	20
in our cohort of	20
in the diagnosis of	20
was not significantly different	20
the risk factors for	20
at the university hospital	20
with median age of	20
half of the patients	20
the major cause of	20
age at time of	20
at the moment of	20
the incidence and severity	20
the total number of	20
in the pediatric population	20
gvhd was observed in	20
in the first months	20
of patients who were	20
consecutive patients who underwent	20
and bone marrow transplantation	20
upper and lower respiratory	20
alone or in combination	20
as well as a	20
over the course of	20
aim of our study	20
is the first report	20
in a multivariate analysis	20
these findings suggest that	20
all of the patients	20
bone marrow transplantation for	20
describe a case of	20
survival in patients with	20
in out of patients	20
the patient was treated	20
major cause of morbidity	20
of the study is	20
who did not receive	20
within the first days	20
at increased risk for	20
on behalf of the	20
matched related or unrelated	20
she was diagnosed with	20
a significant proportion of	19
and disease free survival	19
cell source was peripheral	19
months of age with	19
of idiopathic pneumonia syndrome	19
in up to of	19
of patients who had	19
important role in the	19
at the onset of	19
the best of our	19
hsct in our center	19
in patients with scd	19
a wide range of	19
in an attempt to	19
best of our knowledge	19
received a median of	19
to be safe and	19
patients were transplanted in	19
of peripheral blood stem	19
study was to determine	19
increases the risk of	19
patients who underwent allo	19
received a myeloablative conditioning	19
was to determine the	19
patients were divided into	19
infectious diseases society of	19
with common variable immunodeficiency	19
of patients in the	19
of invasive fungal infections	19
was detected in patients	19
after hematopoietic cell transplantation	19
associated with the development	19
to the best of	19
in recipients of allogeneic	19
we retrospectively reviewed the	19
hematopoetic stem cell transplantation	19
has been described in	19
the source of stem	19
the impact of the	19
is an autosomal recessive	19
in the incidence of	19
group of patients with	19
were significantly higher in	19
was seen in patients	19
study was to compare	19
after allogeneic bone marrow	19
the national institutes of	19
stem cell transplantation and	19
the infectious diseases working	19
standard of care for	19
stem cell transplant patients	19
signs and symptoms of	19
outcomes in patients with	19
is caused by mutations	19
the treatment of choice	19
compared to those with	19
the first year post	19
the patients who received	19
society for blood and	19
risk factors associated with	19
in a child with	19
did not receive any	19
a high risk of	19
and platelet engraftment was	19
the standard of care	18
by the presence of	18
patients with aml in	18
treatment of choice for	18
are at high risk	18
vitro and in vivo	18
at transplant was years	18
has not been previously	18
in the patients with	18
diseases working party of	18
a reduction in the	18
quality of life and	18
presence or absence of	18
be considered in the	18
blood stem cell transplant	18
cumulative incidence of acute	18
have been described in	18
is a frequent complication	18
dose of mg m	18
did not respond to	18
the mean number of	18
main cause of death	18
significant differences between the	18
a member of the	18
is associated with increased	18
was well tolerated and	18
in bone marrow transplant	18
in accordance with the	18
a significant reduction of	18
was performed in patients	18
in this group of	18
of stem cells was	18
not significantly different between	18
most common cause of	18
cell receptor excision circles	18
it is associated with	18
diseases society of america	18
should be considered as	18
year old male with	18
influenza a h n	18
years of age with	18
is the most important	18
was diagnosed in patients	18
we report on a	18
high morbidity and mortality	18
independent risk factor for	18
mobilized peripheral blood stem	18
in neutropenic patients with	18
of this retrospective study	18
to reduce the risk	18
as a consequence of	18
been reported to be	18
with relapsed or refractory	18
for the patients with	18
children and adolescents with	18
the treatment of patients	18
it is possible that	18
was used to compare	18
the cause of death	18
studies have shown that	18
patients at high risk	18
was bone marrow in	18
included in the analysis	18
undergoing allogeneic hematopoietic stem	18
in the field of	18
patients undergoing allogeneic hematopoietic	18
was similar in both	18
party of the european	18
statistical analysis was performed	18
of patients were included	18
compared to patients without	18
risk factors for the	18
the rest of the	18
majority of patients with	18
and risk factors for	18
has not been reported	18
was associated with an	17
after reduced intensity conditioning	17
the intensive care unit	17
inborn errors of immunity	17
the presence of the	17
white blood cell count	17
here we present a	17
and was found to	17
regimen was myeloablative in	17
that the use of	17
patients with chronic gvhd	17
are needed to confirm	17
than years of age	17
due to lack of	17
patients with relapsed or	17
at the university of	17
in any of the	17
was referred to our	17
median of days after	17
we did not find	17
dose chemotherapy and autologous	17
a significant difference in	17
we found that the	17
is a rare autosomal	17
were males and females	17
neutrophil engraftment was days	17
an effective treatment for	17
to better understand the	17
occurred at a median	17
the first report of	17
x kg cd cells	17
cd cells in the	17
did not differ between	17
t cell receptor excision	17
with reduced intensity conditioning	17
influenza a and b	17
as a cause of	17
the central nervous system	17
prospective studies are needed	17
shown to be effective	17
are alive and disease	17
patients were conditioned with	17
are at increased risk	17
the primary endpoint was	17
cell acute lymphoblastic leukemia	17
infections after hematopoietic stem	17
stem cell transplantation recipients	17
in patients with primary	17
highlights the importance of	17
a low incidence of	17
is an effective treatment	17
at time of transplant	17
a subset of patients	17
of pediatric patients with	17
had no impact on	17
the median time between	17
complication of allogeneic hematopoietic	17
mg kg day for	17
is a rare but	17
and progression free survival	17
for the entire cohort	17
the risk of gvhd	17
from diagnosis to transplant	17
the average number of	17
reported in patients with	17
the incidence of chronic	16
infection in patients with	16
the incidence of cmv	16
study was to investigate	16
performed a retrospective analysis	16
of cd cd cd	16
very good partial response	16
outcomes of patients with	16
report the case of	16
a significant cause of	16
chemotherapy followed by autologous	16
were excluded from the	16
in children and adults	16
was observed in all	16
on the th day	16
the mean age was	16
was used as a	16
transplantation for patients with	16
higher in patients with	16
cd cells per kg	16
and all of them	16
our cohort of patients	16
of these patients were	16
of clinical immunology and	16
the goal of this	16
the majority of cases	16
a myeloablative conditioning regimen	16
course of the disease	16
the patients who were	16
the time of analysis	16
we retrospectively analyzed patients	16
incidence of relapse was	16
and risk factors of	16
was successfully treated with	16
the leading cause of	16
this case highlights the	16
incidence of cmv infection	16
as part of a	16
analysis was performed using	16
it is difficult to	16
and bone marrow in	16
are alive and well	16
been associated with a	16
time to neutrophil recovery	16
the most common cause	16
was to compare the	16
patients received myeloablative conditioning	16
is a potentially curative	16
reported to the ebmt	16
received stem cells from	16
and marrow transplant recipients	16
for patients with relapsed	16
cell source was bone	16
one of the main	16
at the beginning of	16
may contribute to the	16
interval from diagnosis to	16
a single dose of	16
to the risk of	16
the patients in the	16
the use of a	16
a group of patients	16
to neutrophil engraftment was	16
no significant differences between	16
we did not observe	16
on the development of	16
and chronic gvhd were	16
after allogeneic haematopoietic stem	16
a heterogeneous group of	16
the entire cohort was	16
syncytial virus infection in	16
probability of overall survival	16
are associated with a	16
a rare autosomal recessive	16
prophylaxis consisted of cyclosporine	16
cd cd t cells	16
of the most common	15
all patients had received	15
undergoing hematopoietic stem cell	15
is a severe complication	15
occurred in of patients	15
is a major cause	15
of respiratory viral infections	15
incidence of acute and	15
is thought to be	15
the treatment of acute	15
we report the case	15
for diagnosis and treatment	15
with a higher risk	15
plays an important role	15
community respiratory virus infections	15
compound heterozygous mutations in	15
prevention and treatment of	15
patients with newly diagnosed	15
all patients were treated	15
undergoing allogeneic stem cell	15
the median dose of	15
patients who received an	15
no significant difference between	15
of the european group	15
overall survival at years	15
in the early phase	15
the patients who had	15
onset noninfectious pulmonary complications	15
of infused cd cells	15
majority of the patients	15
high index of suspicion	15
an important cause of	15
who did not have	15
should be considered for	15
decision was made to	15
in the early post	15
significant difference between the	15
related or unrelated donor	15
for a total of	15
we report the first	15
due to disease progression	15
of acute graft versus	15
one of the patients	15
underwent allogeneic hematopoietic stem	15
the role of the	15
a median time to	15
cd t cells and	15
patients with xiap deficiency	15
was a trend towards	15
the study is to	15
hematopoietic stem cell transplantations	15
from the same donor	15
at increased risk of	15
related morbidity and mortality	15
the presence or absence	15
univariate and multivariate analysis	15
incidence and risk factors	15
and stem cell transplantation	15
number of patients with	15
from the time of	15
the medical records of	15
considered in patients with	15
with full donor chimerism	15
to determine the incidence	15
median number of cd	15
significantly higher in patients	15
the median time for	15
of total body irradiation	15
related or unrelated donors	15
and chronic graft versus	15
in this cohort of	15
in a subset of	15
of acute gvhd was	15
the incidence of grade	15
tumor necrosis factor receptor	15
and mortality after allogeneic	15
in allogeneic hsct recipients	15
the first days post	15
a safe and effective	15
of bone marrow transplantation	15
patient died due to	15
did not show any	15
laboratory of clinical immunology	15
is known to be	15
for the use of	15
patients who do not	15
variants of uncertain significance	15
and lower respiratory tract	15
has not yet been	15
history of recurrent infections	15
the innate immune system	15
first year of life	15
for the presence of	15
cd cell dose was	15
patients included in the	15
alive and disease free	15
pediatric and young adult	15
patients were transplanted from	15
within the first year	15
is a safe and	15
of patients had a	15
as a source of	15
gvhd was seen in	14
with the presence of	14
risk acute myeloid leukemia	14
mg kg on day	14
the patient was diagnosed	14
autologous hematopoietic cell transplantation	14
blood stem cells were	14
known to be associated	14
and the patient was	14
cells in the graft	14
in patients with cancer	14
the natural history of	14
in the evaluation of	14
bacterial and fungal infections	14
of allogeneic hematopoietic cell	14
patients were in complete	14
aim of this retrospective	14
upper respiratory tract infection	14
of these patients had	14
and graft versus host	14
respiratory syncytial virus and	14
admitted to the hospital	14
infections in hematopoietic cell	14
bone marrow failure syndromes	14
evaluate the efficacy of	14
was noted to have	14
was associated with increased	14
no statistically significant differences	14
measured by flow cytometry	14
from matched unrelated donors	14
of the patients are	14
our findings suggest that	14
and respiratory syncytial virus	14
to declare p abstract	14
mg m on days	14
compared to that of	14
seen in patients with	14
patients developed acute gvhd	14
as well as for	14
time to platelet engraftment	14
to the presence of	14
both cd and cd	14
dose chemotherapy with autologous	14
more likely to be	14
median cd cell dose	14
in solid organ transplant	14
disease control and prevention	14
patients who had a	14
characteristics are shown in	14
between january and june	14
a total dose of	14
with higher risk of	14
was admitted to the	14
who underwent allogeneic hematopoietic	14
characteristics of the patients	14
with chronic granulomatous disease	14
status at the time	14
and cd t cell	14
were found in patients	14
analysis was performed by	14
was higher in the	14
and chronic gvhd in	14
and young adults with	14
can be used as	14
autologous bone marrow transplantation	14
in a single center	14
unrelated cord blood transplantation	14
disease of the liver	14
associated with higher risk	14
especially in patients with	14
cell transplantation in children	14
a patient with a	14
and in patients with	14
median time of months	14
on the incidence of	14
in our center from	14
the clinical features of	14
there is a paucity	14
european society for blood	14
who underwent allogeneic hsct	14
the intensity of the	14
at last follow up	14
in patients with pid	14
an increased incidence of	14
no difference in the	14
human metapneumovirus infection in	14
upper respiratory tract infections	14
to evaluate the safety	14
recipients of allogeneic hematopoietic	14
respiratory virus infections after	14
of the gastrointestinal tract	14
acute gvhd occurred in	14
tacrolimus and mycophenolate mofetil	14
the age of months	14
is a paucity of	14
cd ro memory t	14
in patients after allogeneic	14
we would like to	14
analyzed by flow cytometry	14
kg day for days	14
of alloreactive t cells	14
and event free survival	14
in a large cohort	14
among the patients with	14
infections in hematopoietic stem	14
was significantly higher than	14
median dose of cd	14
to the lack of	14
medical records of patients	14
in recipients of hematopoietic	14
clinical immunology and microbiology	14
history was significant for	14
in patients with cgd	14
high dose chemotherapy followed	14
mg m on day	14
the first day of	14
extensive chronic gvhd was	14
incidence and outcome of	14
centers for disease control	14
of the patients developed	14
for disease control and	14
cell transplant recipients with	14
the infectious diseases society	14
and the median time	14
in adults and children	14
for respiratory syncytial virus	14
the european society for	14
there is no consensus	14
in the conditioning regimen	14
after a median time	14
of cd cells infused	14
year overall survival was	14
observed in patients with	14
evaluate the safety and	14
only curative option for	14
stem cell transplantation background	13
deficiency is a rare	13
hsct in children with	13
from a matched sibling	13
were independently associated with	13
survival and overall survival	13
year os and pfs	13
bone marrow and peripheral	13
disease at time of	13
the percentage of patients	13
is associated with an	13
with the diagnosis of	13
in order to evaluate	13
for patients with refractory	13
in all patients with	13
a high mortality rate	13
in a variety of	13
on the presence of	13
the patient had a	13
seems to be a	13
patients who were diagnosed	13
patients received bone marrow	13
as a part of	13
did not reach statistical	13
no differences in the	13
following bone marrow transplantation	13
of acute myeloid leukemia	13
our results indicate that	13
invasive fungal infections in	13
with a high risk	13
and extensive chronic gvhd	13
clinical practice guideline for	13
performed a retrospective chart	13
a negative impact on	13
confirming the diagnosis of	13
was achieved in of	13
appears to be a	13
patients with or without	13
disease at the time	13
age at the time	13
cd and cd cd	13
the start of the	13
gvhd occurred in patients	13
this was a retrospective	13
the first months after	13
fever of unknown origin	13
has not been well	13
acute gvhd of the	13
children with sickle cell	13
one of the major	13
was observed in the	13
the most frequent cause	13
be used as a	13
increased morbidity and mortality	13
common variable immune deficiency	13
to be the most	13
b and t cells	13
in order to reduce	13
to the intensive care	13
of cmv infection in	13
the use of high	13
a treatment option for	13
mg kg day x	13
and were included in	13
the use of the	13
bronchiolitis obliterans syndrome after	13
is the treatment of	13
and was associated with	13
the beginning of the	13
and chronic gvhd was	13
a history of recurrent	13
chart review was performed	13
were the most frequent	13
by the infectious diseases	13
was shown to be	13
be associated with a	13
may be due to	13
factors for the development	13
and were treated with	13
of stem cells in	13
and the need for	13
is associated with higher	13
the authors declare no	13
supportive care in cancer	13
with the aim to	13
and there was no	13
retrospective analysis of patients	13
retrospective study was to	13
and young adult patients	13
are listed in table	13
this retrospective study was	13
to the use of	13
marrow and peripheral blood	13
mortality after allogeneic hematopoietic	13
significant cause of morbidity	13
in the last decade	13
of the immune response	13
the most commonly used	13
during the course of	13
between and were included	13
and platelet engraftment were	13
of the disease and	13
cause of death was	13
haploidentical hsct with pt	13
in patients with non	13
nothing to declare o	13
included in this analysis	13
and one patient had	13
with severe aplastic anemia	13
in of patients and	13
mg kg on days	13
patients who had received	13
with hematopoietic stem cell	13
associated with a reduced	13
of donor t cells	13
cell transplantation is the	13
the small number of	13
a pediatric patient with	13
patients with acute gvhd	13
the use of antimicrobial	13
of the present study	13
for pediatric patients with	13
classified according to the	13
b and t cell	13
is safe and effective	13
here we report the	13
treatment option for patients	13
hematopoietic stem cells transplantation	13
informed consent was obtained	13
when compared to the	13
survival at years was	13
are more likely to	13
pure red cell aplasia	13
there was no evidence	13
in patients undergoing hsct	13
bone marrow transplant doi	13
shown to be associated	13
all but one patient	13
treatment in patients with	13
cd and cd cells	13
were observed in patients	13
patients were in cr	13
she was referred to	13
patients with bone marrow	13
infection in hsct recipients	13
or peripheral blood stem	12
a review of the	12
was no difference between	12
stem cell source and	12
a trend for a	12
a retrospective cohort study	12
was found in patients	12
patients are alive with	12
we describe a patient	12
report the results of	12
out of patients with	12
were not statistically different	12
with the risk of	12
of patients undergoing hsct	12
and the absence of	12
whole exome sequencing was	12
of the use of	12
part of the conditioning	12
consent was obtained from	12
systematic review and meta	12
infections in immunocompromised patients	12
at our institution between	12
day was associated with	12
the patient and the	12
the median overall survival	12
at the dose of	12
specific cytotoxic t lymphocytes	12
csf mobilized peripheral blood	12
as soon as possible	12
of the development of	12
free and overall survival	12
was to investigate the	12
to investigate the role	12
from a matched related	12
we present a patient	12
investigated the role of	12
most common causes of	12
of lung transplant recipients	12
was the only factor	12
children and young adults	12
is a risk factor	12
case of a year	12
with a high mortality	12
adverse events were reported	12
chronic gvhd occurred in	12
group of patients who	12
for patients with acute	12
the patient is a	12
the results of this	12
patients with a history	12
we report the results	12
cumulative incidence of agvhd	12
versus host disease in	12
pneumonia in patients with	12
safe and effective in	12
cause of treatment failure	12
in the differential diagnosis	12
was also found to	12
may play a role	12
was used in of	12
and increased risk of	12
on the waiting list	12
in multiple myeloma patients	12
from the start of	12
of patients with primary	12
acute gvhd grade i	12
the overall survival was	12
patients undergoing allogeneic hsct	12
in one of the	12
bacterial and viral infections	12
not reach statistical significance	12
a significant impact on	12
the prognostic impact of	12
the efficacy of the	12
for acute lymphoblastic leukemia	12
here we describe a	12
transplant related mortality was	12
and melphalan mg m	12
performed according to the	12
differences between the two	12
the incidence of agvhd	12
conflicts of interest to	12
in patients transplanted from	12
inherited bone marrow failure	12
in more than of	12
investigate the role of	12
in terms of os	12
at our center between	12
patients who were treated	12
a year old female	12
have an impact on	12
respiratory syncytial virus infections	12
in group a and	12
of sickle cell disease	12
iv acute gvhd and	12
and solid organ transplant	12
in order to prevent	12
regimen was used in	12
free survival and overall	12
percentage of patients with	12
peripheral blood progenitor cells	12
young adult patients with	12
as shown in table	12
newborn screening for scid	12
a larger number of	12
no significant difference was	12
a hematopoietic stem cell	12
a critical role in	12
follow up was months	12
human respiratory syncytial virus	12
granulocyte colony stimulating factor	12
have been used for	12
a lower risk of	12
objective of the study	12
bone marrow biopsy was	12
reduce the incidence of	12
acute gvhd was observed	12
to describe a case	12
goal of this study	12
cells and nk cells	12
baylor college of medicine	12
have been identified in	12
of the patients and	12
the vast majority of	12
is a curative treatment	12
all patients are alive	12
in patients with relapsed	12
bone marrow transplantation unit	12
full donor chimerism was	12
has been used in	12
university school of medicine	12
to be an effective	12
only curative treatment for	12
did not result in	12
was significantly lower than	12
full donor chimerism at	12
patients with dock deficiency	12
significant proportion of patients	12
patients transplanted in cr	12
presented at months of	12
case of a patient	12
old female presented with	12
of extensive chronic gvhd	12
from the infectious diseases	12
a better understanding of	12
significant difference was found	12
in patients with sickle	12
a large number of	12
of patients at risk	12
in order to improve	12
lost to follow up	12
been shown to reduce	12
may need to be	12
the absence of an	12
important risk factor for	12
the ebmt risk score	12
was seen in of	12
was associated with higher	12
of patients with acute	12
by flow cytometry using	12
overall response rate was	12
in sot and hsct	12
with complete donor chimerism	12
we describe a case	12
gvhd of the skin	12
a total of pts	12
hsct or sot recipients	12
regimens were used in	12
not statistically different between	12
here we report a	12
adolescents and young adults	12
a total of children	12
in the use of	12
in the frequency of	12
the gold standard for	12
reduced intensity conditioning regimens	12
data suggest that the	12
the outcome of allogeneic	12
the most common causes	12
who did not develop	12
of adult patients with	12
a case series of	12
reduces the risk of	12
were transplanted in cr	12
blood was used as	12
the characteristics of the	12
the results of our	12
in patients with an	12
and failure to thrive	12
for allogeneic stem cell	12
lymphocytic interstitial lung disease	12
t and nk cells	12
and of the patients	12
median duration of follow	12
patients did not receive	12
a higher number of	12
patients who received hsct	12
from day to day	12
for the detection of	12
and the duration of	12
in the current study	12
compared to the control	12
infection in lung transplant	12
unrelated umbilical cord blood	12
a higher rate of	12
as compared to patients	12
pathogenic or likely pathogenic	11
patients with nonmalignant diseases	11
and no evidence of	11
these data show that	11
the cumulative incidences of	11
risk of cmv reactivation	11
one patient had a	11
in patients who are	11
and peripheral blood stem	11
research is needed to	11
management of patients with	11
vivo t cell depletion	11
a mean age of	11
have nothing to disclose	11
and cyclophosphamide mg kg	11
the clinical course of	11
were detected in the	11
did not have any	11
was also associated with	11
received a reduced intensity	11
innate and adaptive immune	11
is associated with the	11
may be an effective	11
a crucial role in	11
the primary outcome was	11
patients were found to	11
under years of age	11
as a marker of	11
patients with mds and	11
aimed to evaluate the	11
to allogeneic stem cell	11
were not statistically significant	11
of invasive fungal infection	11
the basis of the	11
the quality of the	11
for the identification of	11
treated with high dose	11
was given to patients	11
is based on the	11
the conditioning regimen for	11
a mutation in the	11
before and after hsct	11
at the site of	11
from a matched unrelated	11
cells were isolated from	11
showed a significant increase	11
with respect to the	11
all patients were transplanted	11
the median interval from	11
were significantly lower in	11
prophylaxis was performed with	11
infections in bone marrow	11
showed a trend towards	11
the low number of	11
the use of this	11
is a rare disease	11
our data indicate that	11
a significant number of	11
with total body irradiation	11
this study aims to	11
is yet to be	11
in acute myeloid leukemia	11
this study shows that	11
and disease status at	11
used for gvhd prophylaxis	11
who were diagnosed with	11
our objective was to	11
cd t cells in	11
results suggest that the	11
old female with a	11
in patients with advanced	11
an independent risk factor	11
for graft versus host	11
a larger cohort of	11
pediatric hematopoietic stem cell	11
of t cells in	11
patients received a myeloablative	11
adult lung transplant recipients	11
an increased frequency of	11
for at least months	11
were performed in patients	11
for patients with aml	11
the present study was	11
of patients were in	11
has received honoraria from	11
at a single institution	11
we have developed a	11
the difference was not	11
was detected in the	11
guidelines for diagnosis and	11
to be able to	11
efficacy and toxicity of	11
patients developed chronic gvhd	11
in the group with	11
patients were enrolled in	11
the risk of developing	11
are at risk for	11
have been performed in	11
fi rst complete remission	11
in all patients and	11
the duration of neutropenia	11
to reduce the incidence	11
curative option for patients	11
neutropenic patients with cancer	11
here we present the	11
present a patient with	11
overall survival rate was	11
chronic gvhd was observed	11
fludarabine mg m day	11
is a major complication	11
variant of unknown significance	11
one patient died due	11
the risk of graft	11
was performed in the	11
is the first case	11
lung transplant recipients with	11
mg kg per day	11
with severe combined immunodeficiency	11
well tolerated with no	11
haploidentical bone marrow transplantation	11
a cumulative incidence of	11
and cord blood in	11
conducted a retrospective study	11
even in the absence	11
the incidence of gvhd	11
in the outpatient setting	11
patients with at least	11
after haematopoietic stem cell	11
patients with severe aplastic	11
this cohort of patients	11
was referred to the	11
to the conditioning regimen	11
cyclophosphamide mg kg and	11
in adult recipients of	11
our results show that	11
the differential diagnosis of	11
relapse or progression of	11
at time of transplantation	11
and was treated with	11
in solid organ transplantation	11
assessed by flow cytometry	11
the first months of	11
over the last decades	11
with at least one	11
characteristics are summarized in	11
associated with a significantly	11
cd ra and cd	11
children and adults with	11
chart review of patients	11
study was approved by	11
in the hsct setting	11
involved in the pathogenesis	11
characteristics and outcomes of	11
patients with hematologic malignancy	11
between and at our	11
two patients had a	11
of blood and marrow	11
with severe hemophilia a	11
not been previously reported	11
p abstract already published	11
followed by autologous hematopoietic	11
the decision was made	11
were similar in both	11
conditioning regimen followed by	11
recurrent respiratory tract infections	11
significantly lower in the	11
statistically significant difference in	11
of neutrophil and platelet	11
conditioning regimens were used	11
as graft versus host	11
in the atg group	11
as a treatment option	11
a high level of	11
and the median age	11
patients with a diagnosis	11
to hematopoietic stem cell	11
here we report our	11
to evaluate the incidence	11
there is a significant	11
she was found to	11
stem cell transplantation as	11
at a single center	11
of the underlying disease	11
of the entire cohort	11
from diagnosis to hsct	11
within the normal range	11
time polymerase chain reaction	11
shown in the table	11
were compared using the	11
and treatment of cancer	11
can be associated with	11
early diagnosis and treatment	11
was higher in patients	11
a wide variety of	11
as the use of	11
this study aimed to	11
with hematologic malignancies and	11
was no evidence of	11
analysis was performed to	11
of cd cells was	11
he continued to have	11
out of the patients	11
the impact of donor	11
main causes of death	11
ranged from to years	11
lower in patients with	11
that the incidence of	11
she did not have	11
evaluate the effect of	11
to be related to	11
age was years old	11
in patients with chronic	11
overall survival in patients	11
in the form of	11
adult blood and marrow	11
a high index of	11
in peripheral blood and	11
was achieved in all	11
on the type of	11
as an alternative to	11
majority of patients were	11
respiratory tract infections in	11
a standard of care	11
an increase in the	11
in patients diagnosed with	11
in the period from	11
cumulative incidence of non	11
does not seem to	11
median time of neutrophil	11
between january and november	11
patients at a median	11
there have been no	11
patients received a median	11
due to graft failure	11
failure to thrive and	11
in the plerixafor group	11
patients with cancer and	11
analysis of patients with	11
due to the lack	11
in pediatric oncology patients	11
describe a patient with	11
patients at risk for	11
the hematopoietic stem cell	11
old male with a	11
blood and bone marrow	11
severe acute respiratory syndrome	11
with recurrent sinopulmonary infections	11
of patients with scd	11
peripheral blood was used	11
the increased risk of	11
iv and grade iii	11
although the number of	11
of nk cells in	10
in immunocompromised patients with	10
common in patients with	10
detection of respiratory viruses	10
received reduced intensity conditioning	10
an increased risk for	10
of patients with hematological	10
therapy with aerosolized ribavirin	10
did not influence the	10
in patients who were	10
low molecular weight heparin	10
patients who underwent haplo	10
compared to patients who	10
in children with cancer	10
of patients with high	10
was used in cases	10
old male presented with	10
from the date of	10
majority of patients received	10
of the impact of	10
has a history of	10
of patients with multiple	10
with the aim of	10
between donor and recipient	10
analysis was performed on	10
our data suggests that	10
patients were transplanted for	10
acute myeloid leukemia patients	10
after the onset of	10
not been reported in	10
it has been shown	10
our knowledge this is	10
in line with the	10
in order to provide	10
we investigated the role	10
analyses were performed using	10
stem cell source in	10
the expression of the	10
chemotherapy and autologous stem	10
pediatric intensive care unit	10
during the neutropenic period	10
vod of the liver	10
morbidity and mortality of	10
it has been reported	10
to lower respiratory tract	10
conditioning regimen consisting of	10
stem cell transplantation has	10
at time of diagnosis	10
to platelet engraftment was	10
therapy for the treatment	10
for patients with multiple	10
in patients undergoing hematopoietic	10
under the age of	10
it is characterized by	10
nothing to declare methods	10
further studies are required	10
study was supported by	10
and stem cell transplant	10
of the transplanted patients	10
important cause of morbidity	10
the first reported case	10
the clinical impact of	10
with aerosolized ribavirin and	10
it is unclear whether	10
patients who received allo	10
soluble tumor necrosis factor	10
hematopoietic cell transplantation in	10
was initially treated with	10
is associated with high	10
among the patients who	10
statistically significant differences in	10
alive at a median	10
all patients who underwent	10
with no signs of	10
patients with cmv reactivation	10
study is needed to	10
significantly associated with the	10
and the lack of	10
used in patients with	10
an allogeneic stem cell	10
stem cell transplantation patients	10
be involved in the	10
of relapse at years	10
method was used to	10
to better define the	10
of cd cd t	10
is a rare complication	10
stem cell sources were	10
of the oral cavity	10
therapeutic option for patients	10
but there was no	10
a major complication of	10
as early as possible	10
a novel mutation in	10
donor was unrelated in	10
a bone marrow biopsy	10
stem cells from a	10
of stem cell source	10
median number of infused	10
of severe combined immunodeficiency	10
for all patients was	10
a mortality rate of	10
mg kg day and	10
were associated with higher	10
over a period of	10
patients at risk of	10
these data indicate that	10
with higher incidence of	10
kg of body weight	10
mutation in exon of	10
none of our patients	10
were used to assess	10
an effective therapy for	10
in a patient who	10
there are limited data	10
a leading cause of	10
variants of unknown significance	10
this work was supported	10
and reduced intensity conditioning	10
stem cell transplantation was	10
that the presence of	10
of adenovirus infection in	10
of t cells and	10
and the impact of	10
first reported case of	10
remission at the time	10
adverse events related to	10
years of age and	10
the causes of death	10
defined as the first	10
the evaluation of the	10
patient was found to	10
in comparison with the	10
for allogeneic hematopoietic stem	10
patients older than years	10
were randomized to receive	10
with a mean age	10
have no conflict of	10
myeloablative allogeneic stem cell	10
stem cell transplantation after	10
no serious adverse events	10
who was diagnosed with	10
fred hutchinson cancer research	10
were more frequent in	10
between the ages of	10
the probability of survival	10
role in the development	10
improve the outcome of	10
there was no statistical	10
the first dose of	10
are alive in cr	10
source was pb in	10
prognosis of patients with	10
a role in the	10
management of these patients	10
reviewed the medical records	10
had a significantly higher	10
in at least one	10
underwent hematopoietic stem cell	10
had a matched related	10
exome sequencing revealed a	10
limited number of patients	10
for at least days	10
a significant increase of	10
of the patients included	10
there is limited data	10
median age at time	10
curative therapy for patients	10
most frequent cause of	10
the declaration of helsinki	10
were male and female	10
review of patients with	10
median follow up time	10
have been treated with	10
length of hospital stay	10
more common in the	10
os and pfs were	10
in patients transplanted in	10
on day after hsct	10
can be considered as	10
in patients who developed	10
considered in the differential	10
there were patients with	10
was associated with the	10
in patients with leukemia	10
for a variety of	10
and the incidence of	10
in second complete remission	10
in contrast to the	10
at a median age	10
evaluated by flow cytometry	10
grade iii or iv	10
increased the risk of	10
in patients with haematological	10
been previously reported in	10
exome sequencing was performed	10
chart review of all	10
at months after hsct	10
in a larger cohort	10
probably due to the	10
with r r b	10
was more frequent in	10
hutchinson cancer research center	10
in stem cell transplant	10
graft failure was observed	10
related and unrelated donors	10
in sickle cell disease	10
has shown to be	10
one patient died of	10
platelet engraftment was days	10
in patients with agvhd	10
received myeloablative conditioning regimen	10
and mortality in patients	10
an absolute neutrophil count	10
report the first case	10
no significant differences were	10
significantly higher than the	10
and full donor chimerism	10
patients were mobilized with	10
divided into two groups	10
of relapse or progression	10
in of patients with	10
in the diagnosis and	10
with a mortality rate	10
linked chronic granulomatous disease	10
was observed in of	10
were performed according to	10
the patients who underwent	10
myeloablative conditioning regimen with	10
the median day of	10
patients undergoing allogeneic stem	10
risk factor for the	10
our data show that	10
was started at a	10
in a total of	10
was detected in of	10
our institution between and	10
and one patient with	10
in our center between	10
we present our experience	10
a significant reduction in	10
knowledge this is the	10
and the majority of	10
was referred to immunology	10
this is the largest	10
safe and well tolerated	10
was more common in	10
after stem cell infusion	10
statistically significant difference was	10
of these patients is	10
of patients diagnosed with	10
donor hematopoietic stem cell	10
is a rare primary	10
in a study of	10
is a rare and	10
and the risk of	10
in haematopoietic stem cell	10
decrease the risk of	10
as well as their	10
total dose of mg	10
high risk of relapse	10
statistically significant difference between	10
the diagnosis and management	10
and did not receive	10
been reported in patients	10
has been observed in	10
of a cohort of	10
ptcy as gvhd prophylaxis	10
samples from patients with	10
increased risk of relapse	10
samples were collected from	10
gvhd prophylaxis was performed	10
an average age of	10
of umbilical cord blood	10
in complete remission and	10
used in the treatment	10
of interest to disclose	10
received a transplant from	10
were in partial remission	10
studies are required to	10
with a low incidence	10
the overall incidence of	10
the development of agvhd	10
graft vs host disease	10
needed to confirm these	10
whole exome sequencing revealed	10
disease status at the	10
a therapeutic option for	10
the patient presented with	10
in an effort to	10
conditioning was used in	10
in patients suffering from	10
a high number of	10
did not differ significantly	10
needed in order to	10
for autologous stem cell	10
is the first study	10
to the type of	10
the lower limit of	10
a median age at	10
authors have nothing to	10
have a role in	10
and months after hsct	10
differences between the groups	10
chart review was conducted	10
cell transplantation for patients	10
was a significant difference	10
a homozygous mutation in	10
median number of previous	10
of human respiratory syncytial	10
in a median of	10
during the period of	10
significantly lower in patients	10
and is characterized by	10
results of this study	10
engraftment was defined as	10
with the number of	10
who underwent hsct at	10
of our study is	10
the transplant related mortality	10
lymphoma and multiple myeloma	10
compared to those without	10
complication after allogeneic hematopoietic	10
in high risk patients	10
conditioning was myeloablative in	10
both acute and chronic	9
group compared to the	9
and an increase in	9
primary immunodeficiency characterized by	9
remains one of the	9
the majority of pts	9
supported in part by	9
is feasible and safe	9
been reported in the	9
in our institution between	9
outcome in patients with	9
on day and day	9
who do not have	9
was found in the	9
was performed in all	9
the overall survival of	9
to the diagnosis of	9
cohort of pediatric patients	9
of consecutive patients who	9
the mean age of	9
the nature of the	9
we found a significant	9
the time of this	9
there were no statistically	9
cd cd cd cd	9
study was to analyse	9
cells in the peripheral	9
as the presence of	9
for a number of	9
the duration of the	9
and should be considered	9
on d and d	9
stem cell transplant with	9
the analysis of the	9
the efficacy of this	9
up of survivors was	9
a rare primary immunodeficiency	9
memory b cells and	9
pediatric patients with scd	9
a history of severe	9
treatment of multiple myeloma	9
determine the role of	9
with aml in cr	9
cumulative incidence of cgvhd	9
a rare form of	9
was performed using the	9
relapse at years was	9
were divided into groups	9
versus host disease prophylaxis	9
update by the infectious	9
research and treatment of	9
would like to thank	9
whole exome sequencing and	9
associated with higher incidence	9
of the t cell	9
aim was to assess	9
an hla identical sibling	9
the main causes of	9
this was associated with	9
infused cd cell dose	9
total of patients who	9
the national institute of	9
agents in neutropenic patients	9
all patients in the	9
significant increase in the	9
a higher proportion of	9
we hypothesized that the	9
the lower respiratory tract	9
more than of the	9
undergoing bone marrow transplantation	9
was found in of	9
to evaluate the effect	9
increase the number of	9
the most important risk	9
mortality in patients undergoing	9
isolated from peripheral blood	9
the primary endpoint of	9
was significantly better in	9
food and drug administration	9
of stem cell transplantation	9
did not differ in	9
cd t cell counts	9
time to engraftment was	9
os and dfs were	9
is protected by copyright	9
as well as increased	9
the two groups were	9
it is also important	9
of t cell receptor	9
aim of the present	9
intensity of the conditioning	9
the most common indication	9
patients undergoing hematopoietic stem	9
similar to those of	9
as a stem cell	9
patients with aml and	9
was the most frequent	9
one year after hsct	9
option for children with	9
cells in patients with	9
associated with significant morbidity	9
for patients who underwent	9
allogeneic hematopoietic stem cells	9
for patients in cr	9
our study is to	9
safety and feasibility of	9
median time for neutrophil	9
who received hsct from	9
institutes of health consensus	9
is also important to	9
retrospective analysis of the	9
of the pi k	9
the protective effect of	9
of a year old	9
in univariate and multivariate	9
of patients are alive	9
stem cell transplant for	9
bone marrow mononuclear cells	9
significant differences were observed	9
of patients with pid	9
hematopoietic stem cells in	9
are known to cause	9
diagnosis to hsct was	9
data of patients with	9
were treated with a	9
the primary objective of	9
in the control of	9
in patients with mm	9
risk of graft failure	9
the end of treatment	9
with high risk of	9
in and of patients	9
patients with mm who	9
have been used in	9
is associated with significant	9
approved for treatment of	9
conditioning allogeneic stem cell	9
was the main cause	9
cells as well as	9
of unknown significance in	9
deaths were due to	9
this article is protected	9
were not associated with	9
allogeneic hematopoetic stem cell	9
in patients with lymphoma	9
been associated with increased	9
of mg kg day	9
increased risk of developing	9
were no statistically significant	9
clinical and laboratory findings	9
these results indicate that	9
car t cells were	9
in one patient and	9
were not able to	9
patients with mixed chimerism	9
patients were male and	9
cell transplantation is a	9
a very poor prognosis	9
viral and fungal infections	9
to the start of	9
to the fact that	9
complication after allogeneic stem	9
the main objective of	9
acute gvhd grade iii	9
were classified according to	9
be due to the	9
has been previously reported	9
the use of atg	9
median time of onset	9
be associated with an	9
a median dose of	9
up time was months	9
is likely to be	9
performed a retrospective study	9
cd cells infused was	9
between the three groups	9
confirmed the presence of	9
patients were followed for	9
compared to those who	9
as part of their	9
cd cells on day	9
with no difference between	9
donor chimerism at day	9
has not been established	9
is associated with poor	9
our understanding of the	9
was used in all	9
as well as other	9
virus lower respiratory tract	9
were associated with increased	9
the outcomes of patients	9
median follow up for	9
over the age of	9
the morbidity and mortality	9
due to the high	9
a significant risk of	9
infections in the immunocompromised	9
the absence of a	9
was defined as a	9
the mechanism of action	9
risk factors and outcomes	9
did not have a	9
viral infections in hematopoietic	9
the clinical and laboratory	9
human metapneumovirus and respiratory	9
in a mouse model	9
was no statistical difference	9
cd ra cd l	9
associated with development of	9
of patients was years	9
article is protected by	9
is characterized by the	9
conducted a retrospective review	9
incidence of relapse in	9
be related to the	9
risk factors and outcome	9
here we report on	9
significant difference in os	9
to the ebmt registry	9
significantly different between the	9
t and b lymphocytes	9
nk cells in the	9
american university of beirut	9
were shown to be	9
and activator of transcription	9
of recurrent infections and	9
number of cd cd	9
patients were transplanted with	9
survival of patients with	9
metapneumovirus and respiratory syncytial	9
due to progressive disease	9
the institutional review board	9
combination therapy with aerosolized	9
months after initiation of	9
this study was supported	9
of cd cells on	9
we aimed to determine	9
this retrospective study we	9
with an incidence of	9
mg kg day on	9
of at least one	9
oncology and stem cell	9
it was decided to	9
the percentage of th	9
anaplastic large cell lymphoma	9
after the end of	9
no differences were observed	9
were excluded from this	9
cmv reactivation occurred in	9
and none of the	9
the use of plerixafor	9
pho and hsct patients	9
multivariate cox regression analysis	9
the outcome of the	9
a decrease in the	9
protocol was approved by	9
larger cohort of patients	9
are in line with	9
prophylaxis consisted of csa	9
infections in hsct recipients	9
use of antimicrobial agents	9
and there is no	9
at least one grade	9
further studies are warranted	9
with high morbidity and	9
hsct levels at months	9
in the first years	9
are presented in table	9
time to onset of	9
and years of age	9
of patients suffering from	9
or secondary graft failure	9
all of them received	9
in the mel group	9
of antimicrobial agents in	9
for patients with severe	9
in the univariate analysis	9
in acute and chronic	9
ct scan of the	9
and stem cell source	9
a mouse model of	9
in this prospective study	9
peripheral blood samples were	9
the presence of gvhd	9
of oral mucositis in	9
a median time from	9
as a predictor of	9
the use of post	9
did not receive ivig	9
risk of relapse and	9
from months to years	9
had full donor chimerism	9
fluorescence in situ hybridization	9
packed red blood cells	9
of our patients had	9
and secondary graft failure	9
ex vivo expansion of	9
difference was not statistically	9
variant of uncertain significance	9
may serve as a	9
adult bone marrow transplant	9
cyclosporine a and methotrexate	9
the centers for disease	9
patients received a reduced	9
the risk of cmv	9
mg kg day i	9
was treated with a	9
and in one case	9
and for patients with	9
does not appear to	9
and peripheral blood in	9
in terms of overall	9
by flow cytometry and	9
confirmed by sanger sequencing	9
was not statistically different	9
prior to transplant and	9
full donor chimerism in	9
a short course of	9
was supported by a	9
the first days of	9
an allogeneic hematopoietic stem	9
the presence of an	9
the use of ric	9
in patients at high	9
described in patients with	9
in the proportion of	9
a graft from a	9
results of a phase	9
syncytial virus infections in	9
in complete remission at	9
as a complication of	9
study was to identify	9
do not have a	9
in the patients who	9
majority of patients had	9
standard of care in	9
over years of age	9
a statistically significant difference	9
as well as to	9
of regulatory t cells	9
adult patients with acute	9
has emerged as a	9
was used to identify	9
dose of cd cells	9
study included patients with	9
transducer and activator of	9
large cohort of patients	9
cord blood stem cells	9
our center between and	9
of acute lymphoblastic leukemia	9
be an effective treatment	9
adverse events were observed	9
the immune system in	9
with a reduction in	9
the second most common	9
excluded from the analysis	9
had a diagnosis of	9
a randomized controlled trial	9
susceptibility to mycobacterial disease	9
severe t cell lymphopenia	9
potential risk factors for	9
report the outcome of	9
terms of overall survival	9
important to note that	9
were obtained from the	9
disease status at transplant	9
were transplanted from a	9
with a mean of	9
antimicrobial agents in neutropenic	9
practice guideline for the	9
a haploidentical family donor	9
in a series of	9
median time to relapse	9
all patients except one	9
for research and treatment	9
was associated with more	9
the use of g	9
before start of conditioning	9
asct in patients with	9
and allogeneic hematopoietic stem	9
of patients with the	9
patients with active disease	9
hsct between january and	9
determined by flow cytometry	9
upper or lower respiratory	9
associated with the risk	9
the pediatric intensive care	9
patients received hsct from	9
for the patients who	9
the conditioning regimen and	9
in of the cases	9
for hematopoietic cell transplantation	9
for severe combined immunodeficiency	9
patients are shown in	9
in paediatric patients with	9
for patients with a	9
a wide spectrum of	9
are similar to those	9
infections in transplant recipients	9
cells in peripheral blood	9
cd cd cd ra	9
for bone marrow transplantation	9
not significantly associated with	9
absolute counts of cd	9
has been studied in	9
to those who did	9
engraftment occurred on day	9
underwent autologous stem cell	9
this study suggests that	9
after allogeneic peripheral blood	9
signal transducer and activator	9